Metabolic and Bariatric Surgery · 23 January 2024

Short-Term Metabolic Improvements Following Roux-en-Y Gastric Bypass

The study investigated the metabolic changes and physiological factors mediating the effects of Roux-en-Y gastric bypass (RYGB) surgery in obese patients. Results showed that insulin concentrations decreased significantly after the surgery, along with improvements in weight loss and insulin sensitivity. Additionally, triglycerides, remnant cholesterol, lactate, glycoprotein acetyls, and certain amino acids decreased post-surgery. The study highlighted that weight loss and improved insulin sensitivity were the key physiological outcomes mediating the short-term metabolic benefits of RYGB surgery.

Journal Article by Zhao S, Hörkkö S (…) Hukkanen J et 4 al. in Obes Surg

read the whole article in Obes Surg

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in Metabolic and Bariatric Surgery.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

The latest stitches

Surg Endosc29 Sep 2026

Endoscopic Sleeve Gastroplasty Offers Safer Alternative to LSG

Endoscopic sleeve gastroplasty (ESG) provides moderate weight loss with a lower risk of complications compared to laparoscopic sleeve gastrectomy (LSG), making it a viable option for patients, particularly those with existing gastro-esophageal reflux disease (GERD).

Ann Surg13 Jul 2026

Predictive Models Enhance Diabetes Remission After Surgery

A new calculator predicts type 2 diabetes remission outcomes for patients post-metabolic surgery, improving patient selection.

Ann Surg16 Jun 2026

EndoBarrier Shows Promise for Type 2 Diabetes in Obesity

Endoscopic duodenal-jejunal bypass liner may significantly improve glycemic control and weight loss in patients with poorly controlled type 2 diabetes and obesity.

All papers in Metabolic and Bariatric Surgery →